<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>112(3)</volume><submitter>Cuccaro A</submitter><pubmed_abstract>Hodgkin lymphoma (HL) is a neoplastic disease in which the inflammatory microenvironment plays a pivotal role in the tumorigenesis. Neutrophilia is a typical finding in HL at diagnosis and, in particular, in association with lymphocytopenia, is a negative prognostic factor. As the immune checkpoint Programmed Death (PD)-L1/PD-1 has become an important therapeutic target, we were interested in the expression of PD-L1 in peripheral blood (PB) leukocytes using flow cytometry and RT-PCR in patients with HL and healthy controls. Granulocytes were the major PB cell fraction expressing PD-L1. PD-L1 expression on granulocytes was higher in patients with HL than in controls and correlated with lower T-cell numbers in PB. We analyzed for associations between PD-L1 expression in PB granulocytes at th</pubmed_abstract><journal>Journal of leukocyte biology</journal><pagination>539-545</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9542012</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma.</pubmed_title><pmcid>PMC9542012</pmcid><pubmed_authors>Martini M</pubmed_authors><pubmed_authors>Corrente F</pubmed_authors><pubmed_authors>Fatone F</pubmed_authors><pubmed_authors>Giordano A</pubmed_authors><pubmed_authors>Bellesi S</pubmed_authors><pubmed_authors>Zangrilli I</pubmed_authors><pubmed_authors>De Stefano V</pubmed_authors><pubmed_authors>Alma E</pubmed_authors><pubmed_authors>Cupelli E</pubmed_authors><pubmed_authors>Maiolo E</pubmed_authors><pubmed_authors>Annunziata S</pubmed_authors><pubmed_authors>Galli E</pubmed_authors><pubmed_authors>Rufini V</pubmed_authors><pubmed_authors>Larocca LM</pubmed_authors><pubmed_authors>Cuccaro A</pubmed_authors><pubmed_authors>Viscovo M</pubmed_authors><pubmed_authors>D'Alo F</pubmed_authors><pubmed_authors>Hohaus S</pubmed_authors></additional><is_claimable>false</is_claimable><name>PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma.</name><description>Hodgkin lymphoma (HL) is a neoplastic disease in which the inflammatory microenvironment plays a pivotal role in the tumorigenesis. Neutrophilia is a typical finding in HL at diagnosis and, in particular, in association with lymphocytopenia, is a negative prognostic factor. As the immune checkpoint Programmed Death (PD)-L1/PD-1 has become an important therapeutic target, we were interested in the expression of PD-L1 in peripheral blood (PB) leukocytes using flow cytometry and RT-PCR in patients with HL and healthy controls. Granulocytes were the major PB cell fraction expressing PD-L1. PD-L1 expression on granulocytes was higher in patients with HL than in controls and correlated with lower T-cell numbers in PB. We analyzed for associations between PD-L1 expression in PB granulocytes at th</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-19T04:46:37.233Z</modification><creation>2025-04-19T04:46:37.233Z</creation></dates><accession>S-EPMC9542012</accession><cross_references><pubmed>35060170</pubmed><doi>10.1002/JLB.5AB0121-041R</doi></cross_references></HashMap>